dc.contributor.author | Tuncer-Ertem, Gunay | |
dc.contributor.author | Yuksel, Esma | |
dc.contributor.author | Hakyemez, Ismail Necati | |
dc.contributor.author | MERİÇ KOÇ, MELİHA | |
dc.contributor.author | Cinar, Gule | |
dc.contributor.author | TOKA, ONUR | |
dc.contributor.author | Yoruk, Gulsen | |
dc.contributor.author | Ataman-Hatipoglu, Cigdem | |
dc.contributor.author | Sarigul, Figen | |
dc.contributor.author | SIRMATEL, FATMA | |
dc.contributor.author | Imre, Ayfer | |
dc.contributor.author | MISTANOĞLU ÖZATAĞ, DURU | |
dc.contributor.author | KARAKEÇİLİ, FARUK | |
dc.contributor.author | URAL, ONUR | |
dc.contributor.author | SÜMER, ŞUA | |
dc.contributor.author | Aktug-Demir, Nazlim | |
dc.contributor.author | Kadanali, Ayten | |
dc.contributor.author | Ucer, Sengul | |
dc.contributor.author | Gunal, Ozgur | |
dc.contributor.author | Ozkaya, Hacer Deniz | |
dc.contributor.author | Yenilmez, Ercan | |
dc.contributor.author | Cetinkaya, Riza Aytac | |
dc.contributor.author | Celik, Ilhami | |
dc.contributor.author | YILMAZ, EMEL | |
dc.contributor.author | Evik, Guliz | |
dc.contributor.author | Kaya, Ali | |
dc.contributor.author | Suer, Kaya | |
dc.contributor.author | Saltoglu, Nese | |
dc.contributor.author | Comoglu, Senol | |
dc.contributor.author | KORKMAZ, PINAR | |
dc.contributor.author | Demirturk, Nese | |
dc.contributor.author | Batirel, Ayse | |
dc.contributor.author | Tulek, Necla | |
dc.contributor.author | Ozguler, Muge | |
dc.contributor.author | Harman, Rezan | |
dc.contributor.author | Bestepe-Dursun, Zehra | |
dc.date.accessioned | 2021-03-03T09:20:28Z | |
dc.date.available | 2021-03-03T09:20:28Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | KORKMAZ P., Demirturk N., Batirel A., Tulek N., Ozguler M., Harman R., Cinar G., TOKA O., Yoruk G., Ataman-Hatipoglu C., et al., "Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies", KLIMIK JOURNAL, cilt.32, sa.3, ss.265-274, 2019 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_1c848444-bc56-431d-ada5-7b9e4234eb65 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/24410 | |
dc.identifier.uri | https://doi.org/10.5152/kd.2019.73 | |
dc.description.abstract | Objective: Both chronic hepatitis B (CHB) and hepatosteatosis may lead to necroinflammation in liver. Therefore, the presence of hepatosteatosis might negatively affect the efficacy of antiviral therapy. We aimed to determine the effect of hepatosteatosis on virological response in patients with CHB receiving entecavir (ETV) and tenofovir (TDF) treatment. | |
dc.language.iso | eng | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Mikrobiyoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.title | Effect of Hepatosteatosis on the Virological Response in Entecavir and Tenofovir Therapies | |
dc.type | Makale | |
dc.relation.journal | KLIMIK JOURNAL | |
dc.contributor.department | Kütahya Sağlık Bilimleri Üniversitesi , Tıp Fakültesi , Enfeksiyon Hastalıkları Ve Klinik Mikrobiyoloji | |
dc.identifier.volume | 32 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 265 | |
dc.identifier.endpage | 274 | |
dc.contributor.firstauthorID | 271883 | |